Inhibition of the DNA amplification of trypanosomes present in tsetse flies midguts: implications for the identification of trypanosome species in wild tsetse flies by Ravel S., Mariani C., Grébaut P., Jamonneau V., Cuisance D., Cuny G.

Get full text

Development of an ALK2-biased BMP type I receptor kinase inhibitor. by Mohedas, A, Xing, X, Armstrong, K, Bullock, A, Cuny, G, Yu, P

Domestic animals as potential reservoir hosts of Trypanosoma brucei gambiense in sleeping sickness foci in Cameroon by Njiokou F., Nimpaye H., Simo G., Njitchouang G.R., Asonganyi T., Cuny G., Herder S.

Get full text

Epidemiological study of canine Trypanosomosis in an urban area of Ivory coast by Keck N., Herder S., Kaba D., Solano P., Gomez J., Cuny G., Davoust B.

Get full text

Trypanosoma vivax, T. congolense “forest type” and T. simiae: prevalence in domestic animals of sleeping sickness foci of Cameroon by Nimpaye H., Njiokou F., Njine T., Njitchouang G.R., Cuny G., Herder S., Asonganyi T., Simo G.

Get full text

Activation loop targeting strategy for design of receptor-interacting protein kinase 2 (RIPK2) inhibitors by Suebsuwong, C, Pinkas, D, Ray, S, Bufton, J, Dai, B, Bullock, A, Degterev, A, Cuny, G

Structure-activity relationship of 3,5-diaryl-2-aminopyridine ALK2 inhibitors reveals unaltered binding affinity for fibrodysplasia ossificans progressiva causing mutants. by Mohedas, A, Wang, Y, Sanvitale, C, Canning, P, Choi, S, Xing, X, Bullock, A, Cuny, G, Yu, P

In vivo enhancement of peptide display by MHC class II molecules with small molecule catalysts of peptide exchange. by Call, M, Xing, X, Cuny, G, Seth, N, Altmann, D, Fugger, L, Krogsgaard, M, Stein, R, Wucherpfennig, K

Review on the Molecular Tools for the Understanding of the Epidemiology of Animal Trypanosomosis in West Africa by Duvallet G, de La Rocque S, Reifenberg JM, Solano P, Lefrançois T, Michel JF, Bengaly Z, Sidibe I, Cuisance D, Cuny G

Get full text

A new class of small molecule inhibitor of BMP signaling. by Sanvitale, C, Kerr, G, Chaikuad, A, Ramel, M, Mohedas, A, Reichert, S, Wang, Y, Triffitt, J, Cuny, G, Yu, P, Hill, C, Bullock, A

Inflammatory signaling by NOD-RIPK2 is inhibited by clinically relevant type II kinase inhibitors by Canning, P, Ruan, Q, Schwerd, T, Hrdinka, M, Maki, J, Saleh, D, Suebsuwong, C, Ray, S, Brennan, P, Cuny, G, Uhlig, H, Gyrd-Hansen, M, Degterev, A, Bullock, A